🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

Recruitingn/aAges 18 Years - anyAllADVANCED MARKER DISCOVERY S.L.
NCT06889883 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective, multicenter, case-control study. The aim is to develop an optimized algorithm by combining the levels of molecular markers in plasma together with risk factors for developing colorectal cancer and clinical data of patients diagnosed with CRC or AA and healthy individuals.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients over the age of 18 who are able to understand the participant information and sign the informed consent. * Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC). Exclusion Criteria: * Patients who had developed any type of cancer in the 5 years prior to their participation in this study. * Patients who have received previous chemotherapy or radiotherapy. * Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome. * Patients with inadequate bowel preparation for colonoscopy. * Patients who have undergone colonoscopy/polipectomy in the previous 5 years. * Patients with hemolyzed plasma.
💊

What it tests

  • Not listed
📍

Where

9 sites
Hospital Clinico Universitario Lozano Blesa
Zaragoza, Spain
Hospital Universitario de Cruces
Bilbao, Spain
Policlinica Gipuzkoa Hospital
Donostia / San Sebastian, Spain
Hospital Universitario Marques de Valdecilla
Santander, Spain
Hospital Universitario de Salamanca
Salamanca, Spain
Hospital Sant Rafael
Barcelona, Spain
Hospital Universitario Vall d' Hebron
Barcelona, Spain
MD Anderson Cancer Centre
Madrid, Spain

…and 1 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy